UCL researchers launch congenital muscular dystrophy research programme
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Read More
Author: Emily Kimber
Noah Goodman
Kymera Therapeutics has appointed Noah Goodman as Chief Business Officer
Read More
Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
The SHIELD-Utah study compared Novavax’s vaccine to the Pfizer/BioNTech mRNA 2024-2025 vaccine
Read More
Russell Abberley
ABPI has appointed Russell Abberley as President-elect
Read More
FDA approves Click’s digital therapeutic for episodic migraine
More than 37 million adults in the US are affected by migraine
Read More- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
